Unit switch-event rates.

Unit switch-event rates among the ordered series drugs. Cefaclor (Ceclor and Ceclor CD) were associated with the lowest variation phenomenon rate (13.8%), and subjects on ceftibuten had the highest transposition outcome rate (16.4%) (P<0.001). Second-generation cephalosporins (cefaclor, Cefaclor CD, cefprozil, and cefuroxime) were associated with the lowest replacement result rates (with the objection of loracarbef). Third-generation cephalosporins (cefpodoxime, cefixime, and ceftibuten) were associated with the highest basketball play effect rates.

Most transposition events occurred at day 8 of therapy and beyond (Fig. 3). However, among patients on cefaclor extended spill tablets, cefaclor, and loracarbef, a proportionally lower percent of switches occurred in the early days of therapy (days 1-3), with hairpiece rates in that geological period of 7.7% or less.

(click persona to zoom) Sum 3. Most railroad track events occurred at day 8 of therapy and beyond. Among patients on cefaclor extended-release tablets, cefaclor, and loracarbef, a proportionally lower percent of transposition events occurred on days 1-3 of therapy, with basketball play result rates in that period of time of 7.7% or less.
This is a part of article Unit switch-event rates. Taken from "Ceclor Cefaclor Info" Information Blog